To include your compound in the COVID-19 Resource Center, submit it here.

Multaq dronedarone regulatory update

EMA's CHMP expanded its safety review of Sanofi's Multaq dronedarone after the company discontinued

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE